RELEEV Cold Sore Treatment (Merix Pharmaceutical Corp.)
Welcome to the PulseAid listing for the RELEEV Cold Sore Treatment drug offered from Merix Pharmaceutical Corp.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merix Pharmaceutical Corp. |
| NON-PROPRIETARY NAME: | Benzalkonium Chloride |
| SUBSTANCE NAME: | BENZALKONIUM CHLORIDE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2006-06-01 |
| END MARKETING DATE: | 0000-00-00 |
RELEEV Cold Sore Treatment HUMAN OTC DRUG Details:
| Item Description | RELEEV Cold Sore Treatment from Merix Pharmaceutical Corp. |
| LABELER NAME: | Merix Pharmaceutical Corp. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | 1.3(mg/mL) |
| START MARKETING DATE: | 2006-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63287-419_46bcc469-674e-1857-e054-00144ff8d46c |
| PRODUCT NDC: | 63287-419 |
| APPLICATION NUMBER: | part333A |